Overexpression of the transcription factor HAC1 improves nerolidol production in engineered yeast

Zhenzhen Qu,Lili Zhang,Shaoming Zhu,Wei Yuan,Jiawei Hang,Dong Yin,Xuechao Tang,Jianyong Zheng,Zhao Wang,Jie Sun
DOI: https://doi.org/10.1016/j.enzmictec.2019.109485
IF: 3.705
2020-03-01
Enzyme and Microbial Technology
Abstract:<p>Increasing the metabolic flux of the mevalonate pathway, reducing the metabolic flux of competing pathway and utilizing the diauxie-inducible system constructed by <em>GAL</em> promoters are strategies commonly used in yeast metabolic engineering for the production of terpenoids. Using these strategies, we constructed a series of yeast strains with a strengthened mevalonate pathway and finally produced 336.5 mg/L nerolidol in a shake flask. The spliced <em>HAC1</em> mRNA assay indicated that the unfolded protein response (UPR) occurred in the strains that we constructed. UPR strains exhibited the low transcriptional activities of <em>GAL1</em> promoter. <em>HAC1</em>-overexpressing strain exhibited dramatically enhanced transcriptional activity of <em>GAL1</em> promoter at 72 h of fermentation in flasks. <em>HAC1</em> overexpression also increased the nerolidol titer by 47.7 %, reaching 497.0 mg/L and increased cell vitality. RNA-seq showed that the genes whose transcription responded to <em>HAC1</em>-overexpression were involved in the regulation of monocarboxylic acid metabolic processes and cellular amino acid biosynthetic process, indicating that the metabolic regulation may be part of the reason of the improved nerolidol synthesis. Our findings enrich the knowledge of the relationship between the construction of sesquiterpene-producing cell factories and UPR regulation. This study provides an effective strategy for sesquiterpene production in yeast.</p>
biotechnology & applied microbiology
What problem does this paper attempt to address?